Article Details

WuXi Biologics Receives U.S. Patent for Proprietary Bispecific Antibody Technology ...

Retrieved on: 2024-01-17 13:24:49

Tags for this article:

Click the tags to see associated articles and topics

WuXi Biologics Receives U.S. Patent for Proprietary Bispecific Antibody Technology .... View article details on HISWAI: https://www.marketscreener.com/quote/stock/WUXI-BIOLOGICS-CAYMAN-INC-37230806/news/WuXi-Biologics-Receives-U-S-Patent-for-Proprietary-Bispecific-Antibody-Technology-Platform-WuXiBody-45755262/

Excerpt

... Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates ... The Company has WuXiBody bispecific antibody platform, SDArBodY ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up